X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ChemMedChem

期刊標題檢索 CHEMMEDCHEM 最新評論: It takes about 10 days to transition from an editor to a reviewer. Wi... (2023-02-19)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ChemMedChem]您好,您是該頁面的第 71594 位訪客。

期刊簡介
期刊名稱ChemMedChem ChemMedChem
LetPub Score
6.7
51 ratings
Rate

Reputation
7.6

Influence
5.4

Speed
9.6

期刊簡稱CHEMMEDCHEM
ISSN1860-7179
E-ISSN1860-7187
h-index92
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.700.7610.750
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: General Pharmacology, Toxicology and Pharmaceutics
Q19 / 80
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Organic Chemistry
Q256 / 211
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q298 / 313
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Drug Discovery
Q253 / 157
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Biochemistry
Q2155 / 438
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Molecular Medicine
Q270 / 178

自引率 (2023-2024)2.80%自引率趨勢
掲載範囲
Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies.

ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs.

Contents
ChemMedChem publishes an attractive mixture of:

Full Papers and Communications
Reviews and Minireviews
Patent Reviews
Highlights and Concepts
Book and Multimedia Reviews.
官方網站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187
在線稿件提交https://www.editorialmanager.com/CMDC
開放訪問No
出版商John Wiley and Sons Ltd
主題領域医学
出版國/地區GERMANY
發行頻率月刊
創刊年2006
每年文章數202每年文章數趨勢
黃金OA百分比27.09%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CHEMISTRY, MEDICINALSCIEQ231/72
PHARMACOLOGY & PHARMACYSCIEQ294/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1860-7179%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: About 75%
參考鏈接
相關期刊 【ChemMedChem】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498333
    PHYTOMEDICINE340302
    LIFE SCIENCES285773
    International Journal of Pharmaceutics242442
    PHARMACOLOGICAL RESEARCH241291
    European Journal of Pharmacology204249
    BIOCHEMICAL PHARMACOLOGY202697
    JOURNAL OF NATURAL PRODUCTS196696
    BRITISH JOURNAL OF PHARMACOLOGY165143
    MOLECULAR PHARMACEUTICS162835
  •  

    ChemMedChem ChemMedChem
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [ChemMedChem] 的評論撰寫評論
作者: shiche


領域: 化学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2023-02-19 09:02:03 評論於
It takes about 10 days to transition from an editor to a reviewer. Within 7 days, they send minor revision comments. After replying to the comments, it takes only 3 days for temporary acceptance. It took less than a month from submission to acceptance. It's just that this year's demotion is very difficult to bear.
(0) 讚! | shiche

作者: 四风翠莲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-09 13:04:47 評論於
Is the return of this journal very slow for the first time? It's been a month and my paper has been under review for just 1 day
(0) 讚! | 四风翠莲

作者: 2020140064


領域: 化学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2021-05-24 15:37:05 評論於
The first round of review took a whole month, with two reviewers providing contrasting evaluations - one negative and one positive. The editor suggested in the letter that the paper could be submitted to Chemistry Select and also mentioned the possibility of seeking additional reviewers. After requesting a third reviewer from another country, the process sped up significantly. The following day, the status changed to "peer review," and after 10 days, feedback was received. The third reviewer recommended language polishing. After one week of language polishing, the paper was accepted.
(17) 讚! | 2020140064

作者: Beacher MacPherson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-07-06 23:32:28 評論於
I would like to ask why the copyright agreement cannot be selected as "Not open" in the additional information section of the submission system
(0) 讚! | Beacher MacPherson

作者: Freda Curme


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-06-06 22:42:16 評論於
JMC, a highly recommended pharmaceutical chemistry journal after EJMC, with very dedicated editors!!!!!!
(0) 讚! | Freda Curme

作者: vvv


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2018-06-06 17:33:39 評論於
JMC, after EJMC is very recommended medicinal chemistry journal, editor super serious!!!!!!!
(0) 讚! | vvv

作者: 长拳志飞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-05-19 13:15:20 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0
Experience sharing: The review speed is actually quite fast, with one review per month. After revising, acceptance is received two days later. After uploading the final version, the unformatted file can be found on the website the next day. EJMC is a good choice for submissions
(0) 讚! | 长拳志飞

作者: 香风寻山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-01-31 15:38:01 評論於
Review Speed: 1.0 Experience Sharing: The review was really fast. I submitted it on January 10, 2017 and went home for Chinese New Year. I received a direct acceptance on January 31, which was so lucky. This article was unexpected. It was submitted to MedChemComm on December 26 and got rejected on December 30. Then I resubmitted it to BMC on January 6 and got rejected overnight. Finally, on January 10, I resubmitted it to ChemMedChem. I really didn't expect the impact factor to increase with each submission
(0) 讚! | 香风寻山

作者: leoming


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2017-01-31 15:32:06 評論於
Review is really fast, 2017_01_10 submitted, go home for the New Year, 2017_01_31 the first day of the first month of the first month received direct accept, too lucky.This article is a bit unexpected. On December 26th, MedChemComm declined to accept the draft on December 30th.After switching to BMC on January 6th, it was rejected overnight.The last 10th was changed to ChemMedChem.I did not expect that the IF will be higher and higher.
(2) 讚! | leoming

作者: 洗髓鸿卓


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-21 18:04:25 評論於
Submission success rate: 75.0
Sharing experience: Can articles not related to medicine be published? Thank you!
(0) 讚! | 洗髓鸿卓

作者: 御阪夏烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-21 12:59:42 評論於
Review speed: 3.0
Sharing experience: Can articles unrelated to medicine be published? Thank you!
(0) 讚! | 御阪夏烟

作者: tiger197510@126.com


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-21 10:59:59 評論於
Can an article not related to medicine be published?Thank you!
(1) 讚! | tiger197510@126.com

作者: tiger197510@126.com


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-21 10:59:52 評論於
Can an article not related to medicine be published?Thank you!
(0) 讚! | tiger197510@126.com

作者: 金顶南霜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-07-05 15:10:29 評論於
Review speed: 2.0 | Submission hit rate: 50.0
Experience sharing: During my PhD, I had a paper accepted after a long time. The reviewers requested major revisions, additional data, and even after revisions, it still required major revisions. As a result, it was delayed for almost half a year before acceptance. Graduating students should reconsider submitting their work
(0) 讚! | 金顶南霜

作者: 匿名


領域: 化学科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-03-28 17:08:00 評論於
selectd 2 times, once rejected, received once.Feeling requirements are higher than teaching hem, although the impact factor is not high, but it is more difficult than ASC...The color picture is super expensive, but I can only change it to black and white.
(0) 讚! | 匿名

作者: 北岳山阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-11-02 13:36:43 評論於
SCI also includes abstracting and indexing information from: Medline (NLM), Mosby Yearbooks (Elsevier), Science Citation Index (Thomson Reuters), Science Citation Index Expanded (Thomson Reuters), and Scopus
(0) 讚! | 北岳山阳

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2012-11-02 12:03:00 評論於
SCI also includes examples: Abstracting and Indexing Information: MEDLINE (NLM) or Mosby Yearbooks (Elsevier) or Science Citation Index (Thomson Reuters) or Science Citation Index Expanded (Thomson Reuters) or SCOPUS.

(0) 讚! | 匿名

作者: 九阴新曼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-06-12 19:40:45 評論於
Review Speed: 2.0 | Submission Acceptance Rate: 75.0
Experience Sharing: Not bad, just not well known
(0) 讚! | 九阴新曼

作者: Deirdre Alerander


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-03-06 15:28:10 評論於
if = 3.306 (2010
(0) 讚! | Deirdre Alerander

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2012-03-06 11:39:00 評論於
IF=3.306(2010)
(0) 讚! | 匿名

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-08-20 17:21:00 評論於
Journal Homepage URL: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187
(0) 讚! | 匿名

作者: 匿名


領域: 化学科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-07-18 19:36:00 評論於
is a bit harder than BIOMC, but the quality should be better
(0) 讚! | 匿名

作者: 通背光磊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-07-18 18:06:24 評論於
Slightly more difficult than biomc, but the quality should be better
(0) 讚! | 通背光磊

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [ChemMedChem] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*